Invesco’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Buy |
1,468,148
+35,137
| +2% | +$62.9K | ﹤0.01% | 2559 |
|
|
2025
Q4 | $2.68M | Buy |
1,433,011
+326,238
| +29% | +$627K | ﹤0.01% | 2494 |
|
|
2025
Q3 | $1.42M | Buy |
1,106,773
+267,433
| +32% | +$362K | ﹤0.01% | 2770 |
|
|
2025
Q2 | $1.04M | Buy |
839,340
+314,697
| +60% | +$363K | ﹤0.01% | 2825 |
|
|
2025
Q1 | $619K | Buy |
524,643
+263,067
| +101% | +$404K | ﹤0.01% | 3073 |
|
|
2024
Q4 | $479K | Buy |
261,576
+1,004
| +0.4% | +$1.96K | ﹤0.01% | 3250 |
|
|
2024
Q3 | $443K | Buy |
260,572
+6,718
| +3% | +$11K | ﹤0.01% | 3285 |
|
|
2024
Q2 | $348K | Buy |
253,854
+11,121
| +5% | +$22.5K | ﹤0.01% | 3440 |
|
|
2024
Q1 | $910K | Buy |
242,733
+40,741
| +20% | +$239K | ﹤0.01% | 3036 |
|
|
2023
Q4 | $1.98M | Sell |
201,992
-904,860
| -82% | -$7.4M | ﹤0.01% | 2616 |
|
|
2023
Q3 | $9.24M | Sell |
1,106,852
-74,137
| -6% | -$847K | ﹤0.01% | 1812 |
|
|
2023
Q2 | $15.7M | Buy |
1,180,989
+993,369
| +529% | +$12.1M | ﹤0.01% | 1504 |
|
|
2023
Q1 | $2.17M | Sell |
187,620
-127,861
| -41% | -$1.27M | ﹤0.01% | 2597 |
|
|
2022
Q4 | $2.58M | Buy |
315,481
+203,011
| +181% | +$1.75M | ﹤0.01% | 2545 |
|
|
2022
Q3 | $653K | Sell |
112,470
-3,521
| -3% | -$20.2K | ﹤0.01% | 3112 |
|
|
2022
Q2 | $513K | Buy |
115,991
+4,708
| +4% | +$28.6K | ﹤0.01% | 3312 |
|
|
2022
Q1 | $1.01M | Sell |
111,283
-3,084,507
| -97% | -$35.5M | ﹤0.01% | 3061 |
|
|
2021
Q4 | $65.4M | Buy |
3,195,790
+3,103,297
| +3,355% | +$74.9M | 0.02% | 946 |
|
|
2021
Q3 | $2.36M | Buy |
92,493
+11,198
| +14% | +$332K | ﹤0.01% | 2741 |
|
|
2021
Q2 | $2.84M | Sell |
81,295
-1,100,243
| -93% | -$32M | ﹤0.01% | 2690 |
|
|
2021
Q1 | $39.4M | Sell |
1,181,538
-516,070
| -30% | -$18.1M | 0.01% | 1173 |
|
|
2020
Q4 | $44M | Sell |
1,697,608
-88,123
| -5% | -$1.5M | 0.01% | 1074 |
|
|
2020
Q3 | $17.6M | Buy |
1,785,731
+1,737,939
| +3,636% | +$10M | 0.01% | 1369 |
|
|
2020
Q2 | $165K | Sell |
47,792
-4,495
| -9% | -$15.3K | ﹤0.01% | 3525 |
|
|
2020
Q1 | $160K | Buy |
+52,287
| New | +$214K | ﹤0.01% | 3467 |
|
|
2019
Q2 | – | Sell |
-19,195
| Closed | -$139K | – | 3759 |
|
|
2019
Q1 | $139K | Buy |
19,195
+1,204
| +7% | +$8.71K | ﹤0.01% | 3664 |
|
|
2018
Q4 | $133K | Sell |
17,991
-4,463
| -20% | -$28.3K | ﹤0.01% | 3614 |
|
|
2018
Q3 | $121K | Buy |
22,454
+4,475
| +25% | +$19.2K | ﹤0.01% | 3768 |
|
|
2018
Q2 | $64K | Sell |
17,979
-40,556
| -69% | -$113K | ﹤0.01% | 3794 |
|
|
2018
Q1 | $120K | Sell |
58,535
-4,118,416
| -99% | -$10.7M | ﹤0.01% | 3658 |
|
|
2017
Q4 | $11M | Sell |
4,176,951
-1,006,412
| -19% | -$3.52M | ﹤0.01% | 1519 |
|
|
2017
Q3 | $27.2M | Sell |
5,183,363
-16,778
| -0.3% | -$72.1K | 0.01% | 1043 |
|
|
2017
Q2 | $18.5M | Sell |
5,200,141
-512
| -0% | -$2.06K | 0.01% | 1229 |
|
|
2017
Q1 | $26.9M | Sell |
5,200,653
-122,553
| -2% | -$600K | 0.01% | 1050 |
|
|
2016
Q4 | $20.2M | Buy |
5,323,206
+5,311,184
| +44,179% | +$38.6M | 0.01% | 1150 |
|
|
2016
Q3 | $108K | Sell |
12,022
-90
| -0.7% | -$752 | ﹤0.01% | 3589 |
|
|
2016
Q2 | $85K | Sell |
12,112
-241,695
| -95% | -$2.21M | ﹤0.01% | 3633 |
|
|
2016
Q1 | $2.16M | Buy |
+253,807
| New | +$2.5M | ﹤0.01% | 2418 |
|
|
2015
Q3 | – | Sell |
-1,052
| Closed | -$6K | – | 3934 |
|
|
2015
Q2 | $6K | Buy |
+1,052
| New | +$6.09K | ﹤0.01% | 4127 |
|
|
2015
Q1 | – | Sell |
-186,862
| Closed | -$1.47M | – | 4055 |
|
|
2014
Q4 | $1.47M | Buy |
+186,862
| New | +$1.2M | ﹤0.01% | 2711 |
|
|
2014
Q3 | – | Sell |
-355,718
| Closed | -$2.2M | – | 4114 |
|
|
2014
Q2 | $2.2M | Buy |
355,718
+205,299
| +136% | +$1.03M | ﹤0.01% | 2522 |
|
|
2014
Q1 | $805K | Sell |
150,419
-501,701
| -77% | -$3.17M | ﹤0.01% | 3158 |
|
|
2013
Q4 | $3.41M | Buy |
652,120
+500,900
| +331% | +$2.3M | ﹤0.01% | 2286 |
|
|
2013
Q3 | $835K | Sell |
151,220
-99,760
| -40% | -$346K | ﹤0.01% | 3130 |
|
|
2013
Q2 | $635K | Buy |
+250,980
| New | +$625K | ﹤0.01% | 3163 |
|
Other funds holding PACB
AIM
VCM
NAMA
Invesco's PACB Position: Q1 2026 in Review
Invesco increased its Pacific Biosciences (PACB) stake by 2.5% in Q1 2026, buying an estimated $62.9K and bringing the position to 1,468,148 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2559.
Invesco first reported a position in PACB in Q2 2013 and has held it in 45 quarters since. The position peaked at $65.4M in Q4 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.
- Invesco held 1,468,148 shares of Pacific Biosciences worth $1.94M as of Q1 2026.
- Invesco bought 35,137 Pacific Biosciences shares in Q1 2026, an estimated $62.9K.
- Pacific Biosciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2559 holding.
- Invesco first reported a position in Pacific Biosciences in Q2 2013 and has held it in 45 quarters since.
- Invesco's Pacific Biosciences position peaked at $65.4M in Q4 2021.
- 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.